Procollagen lysyl hydroxylase 2 expression is regulated by an alternative downstream transforming growth factor β-1 activation mechanism

Journal of Biological Chemistry

Volumn 290, Issue 47, 2015, Pages 28465-28476

  Gjaltema, Rutger A F ^a   De Rond, Saskia ^a   Rots, Marianne G ^a   Bank, Ruud A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; ALKYLATION; AMINO ACIDS; BINS; CHEMICAL ACTIVATION; COLLAGEN;

2-OXOGLUTARATE; ACTIVATION MECHANISMS; EPIGENETIC MODIFICATION; HISTONE ACETYLTRANSFERASES; HISTONE METHYLATION; LYSINE RESIDUES; MOLECULAR PROCESS; TRANSFORMING GROWTH FACTOR BETA;

TRANSCRIPTION;

HISTONE ACETYLTRANSFERASE PCAF; HISTONE H3; HISTONE H4; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; HISTONE; PLOD2 PROTEIN, HUMAN; PROCOLLAGEN LYSINE 2 OXOGLUTARATE 5 DIOXYGENASE; PROTEIN SERINE THREONINE KINASE; SMAD3 PROTEIN, HUMAN; TGF-BETA TYPE I RECEPTOR; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; HUMAN CELL; PLOD2 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEPLETION; REGULATORY MECHANISM; ACETYLATION; CELL CULTURE; GENETICS; METABOLISM;

ACETYLATION; CELLS, CULTURED; HISTONES; HUMANS; PROCOLLAGEN-LYSINE, 2-OXOGLUTARATE 5-DIOXYGENASE; PROMOTER REGIONS, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD3 PROTEIN; SP1 TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84947807137     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.634311     Document Type: Article

References (66)

1. Branton, M. H., and Kopp, J. B. (1999) TGF-beta and fibrosis. Microbes Infect. 1, 1349-1365
2. Namazi, M. R., Fallahzadeh, M. K., and Schwartz, R. A. (2011) Strategies for prevention of scars: what can we learn from fetal skin? Int. J. Dermatol. 50, 85-93
3. Wynn, T. A. (2008) Cellular and molecular mechanisms of fibrosis. J. Pathol. 214, 199-210
4. van der Slot, A. J., Zuurmond, A. M., Bardoel, A. F., Wijmenga, C., Pruijs, H. E., Sillence, D. O., Brinckmann, J., Abraham, D. J., Black, C. M., Verzijl, N., De Groot, J., Hanemaaijer, R., Te Koppele, J. M., Huizinga, T. W., and Bank, R. A. (2003) Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J. Biol. Chem. 278, 40967-40972
5. van der Slot, A. J., Zuurmond, A. M., van den Bogaerdt, A. J., Ulrich, M. M., Middelkoop, E., Boers, W., Karel Ronday, H., De Groot, J., Huizinga, T. W., and Bank, R. A. (2004) Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenon. Matrix Biol. 23, 251-257
6. Ricard-Blum, S., Esterre, P., and Grimaud, J. A. (1993) Collagen crosslinking by pyridinoline occurs in non-reversible skin fibrosis. Cell Mol. Biol. 39, 723-727
7. Moriguchi, T., and Fujimoto, D. (1979) Crosslink of collagen in hypertrophic scar. J. Invest. Dermatol. 72, 143-145
8. Takaluoma, K., Lantto, J., and Myllyharju, J. (2007) Lysyl hydroxylase 2 is a specific telopeptide hydroxylase, while all three isoenzymes hydroxylate collagenous sequences. Matrix Biol. 26, 396-403
9. Yamauchi, M., and Sricholpech, M. (2012) Lysine post-translational modifications of collagen. Essays Biochem. 52, 113-133
10. Smith-Mungo, L. I., and Kagan, H. M. (1998) Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 16, 387-398
11. Reiser, K., McCormick, R. J., and Rucker, R. B. (1992) Enzymatic and nonenzymatic cross-linking of collagen and elastin. FASEB J. 6, 2439-2449
12. van der Slot-Verhoeven, A. J., van Dura, E. A., Attema, J., Blauw, B., Degroot, J., Huizinga, T. W., Zuurmond, A. M., and Bank, R. A. (2005) The type of collagen cross-link determines the reversibility of experimental skin fibrosis. Biochim. Biophys. Acta. 1740, 60-67
13. Wiegand, C., and White, R. (2013) Microdeformation in wound healing. Wound Repair Regen. 21, 793-799
14. Balestrini, J. L., Chaudhry, S., Sarrazy, V., Koehler, A., and Hinz, B. (2012) The mechanical memory of lung myofibroblasts. Integr. Biol. 4, 410-421
15. Georges, P. C., Hui, J. J., Gombos, Z., McCormick, M. E., Wang, A. Y., Uemura, M., Mick, R., Janmey, P. A., Furth, E. E., and Wells, R. G. (2007) Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G1147-G1154
16. Perugorria, M. J., Wilson, C. L., Zeybel, M., Walsh, M., Amin, S., Robinson, S., White, S. A., Burt, A. D., Oakley, F., Tsukamoto, H., Mann, D. A., and Mann, J. (2012) Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation. Hepatology 56, 1129-1139
17. Ko, Y. A., Mohtat, D., Suzuki, M., Park, A. S., Izquierdo, M. C., Han, S. Y., Kang, H. M., Si, H., Hostetter, T., Pullman, J. M., Fazzari, M., Verma, A., Zheng, D., Greally, J. M., and Susztak, K. (2013) Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol. 14, R108
18. Sheen-Chen, S. M., Lin, C. R., Chen, K. H., Yang, C. H., Lee, C. T., Huang, H. W., and Huang, C. Y. (2013) Epigenetic histone methylation regulates transforming growth factor β-1 expression following bile duct ligation in rats. J. Gastroenterol. 49, 1285-1297
19. Watson, C. J., Collier, P., Tea, I., Neary, R., Watson, J. A., Robinson, C., Phelan, D., Ledwidge, M. T., McDonald, K. M., McCann, A., Sharaf, O., and Baugh, J. A. (2014) Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype. Hum. Mol. Genet. 23, 2176-2188
20. Coward, W. R., Feghali-Bostwick, C. A., Jenkins, G., Knox, A. J., and Pang, L. (2014) A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis. FASEB J. 28, 3183-3196
21. Tampe, B., Tampe, D., Muller, C. A., Sugimoto, H., Lebleu, V., Xu, X., Muller, G. A., Zeisberg, E. M., Kalluri, R., and Zeisberg, M. (2014) Tet3-Mediated Hydroxy methylation of Epigenetically Silenced Genes Contributes to Bone Morphogenic Protein 7-Induced Reversal of Kidney Fibrosis. J. Am. Soc. Nephrol. 25, 905-912
22. Reik, W. (2007) Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447, 425-432
23. Goding, C. R., Pei, D., and Lu, X. (2014) Cancer: pathological nuclear reprogramming? Nat. Rev. Cancer 14, 568-573
24. Brenet, F., Moh, M., Funk, P., Feierstein, E., Viale, A. J., Socci, N. D., and Scandura, J. M. (2011) DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS ONE 6, e14524
25. Bannister, A. J., and Kouzarides, T. (2011) Regulation of chromatin by histone modifications. Cell Research 21, 381-395
26. Campos, E. I., and Reinberg, D. (2009) Histones: annotating chromatin. Annu. Rev. Genet. 43, 559-599
27. Kooistra, S. M., and Helin, K. (2012) Molecular mechanisms and potential functions of histone demethylases. Nat. Rev. Mol. Cell Biol. 13, 297-311
28. Tee, W. W., and Reinberg, D. (2014) Chromatin features and the epigenetic regulation of pluripotency states in ESCs. Development 141, 2376-2390
29. Veloso, A., Kirkconnell, K. S., Magnuson, B., Biewen, B., Paulsen, M. T., Wilson, T. E., and Ljungman, M. (2014) Rate of elongation by RNA polymerase II is associated with specific gene features and epigenetic modifications. Genome Res. 24, 896-905
30. Berger, S. L. (2007) The complex language of chromatin regulation during transcription. Nature 447, 407-412
31. Ito, T. (2007) Role of histone modification in chromatin dynamics. J. Biochem. 141, 609-614
32. Choi, J. K., and Howe, L. J. (2009) Histone acetylation: truth of consequences? Biochem. Cell Biol. 87, 139-150
33. Mosammaparast, N., and Shi, Y. (2010) Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu. Rev. Biochem. 79, 155-179
34. Klose, R. J., Kallin, E. M., and Zhang, Y. (2006) JmjC-domain-containing proteins and histone demethylation. Nature Reviews. Genetics 7, 715-727
35. Helin, K., and Dhanak, D. (2013) Chromatin proteins and modifications as drug targets. Nature 502, 480-488
36. Remst, D. F., Blaney Davidson, E. N., Vitters, E. L., Bank, R. A., van den Berg, W. B., and van der Kraan, P. M. (2014) TGF-ss induces Lysyl hydroxylase 2b in human synovial osteoarthritic fibroblasts through ALK5 signaling. Cell Tissue Res. 355, 163-171
37. Mia, M. M., Boersema, M., and Bank, R. A. (2014) Interleukin-1beta attenuates myofibroblast formation and extracellular matrix production in dermal and lung fibroblasts exposed to transforming growth factor-beta1. PLoS ONE 9, e91559
38. van der Slot, A. J., van Dura, E. A., de Wit, E. C., De Groot, J., Huizinga, T. W., Bank, R. A., and Zuurmond, A. M. (2005) Elevated formation of pyridinoline cross-links by profibrotic cytokines is associated with enhanced lysyl hydroxylase 2b levels. Biochim. Biophys. Acta 1741, 95-102
39. Consortium, E. P. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74
40. Liu, C., Chen, X., Yang, L., Kisseleva, T., Brenner, D. A., and Seki, E. (2014) Transcriptional repression of the transforming growth factor β (TGFbeta) Pseudoreceptor BMP and activin membrane-bound inhibitor (BAMBI) by Nuclear Factor κB (NF-κB) p50 enhances TGF-β signaling in hepatic stellate cells. J. Biol. Chem. 289, 7082-7091
41. Ryu, J. K., Kim, W. J., Choi, M. J., Park, J. M., Song, K. M., Kwon, M. H., Das, N. D., Kwon, K. D., Batbold, D., Yin, G. N., and Suh, J. K. (2013) Inhibition of histone deacetylase 2 mitigates profibrotic TGF-beta1 responses in fibroblasts derived from Peyronie's plaque. Asian J. Androl. 15, 640-645
42. Fitzgerald O'Connor, E. J., Badshah, II, Addae, L. Y., Kundasamy, P., Thanabalasingam, S., Abioye, D., Soldin, M., and Shaw, T. J. (2012) Histone deacetylase 2 is upregulated in normal and keloid scars. J. Invest. Dermatol. 132, 1293-1296
43. Brinckmann, J., Notbohm, H., Tronnier, M., Açil, Y., Fietzek, P. P., Schmeller, W., Müller, P. K., and Bätge, B. (1999) Overhydroxylation of lysyl residues is the initial step for altered collagen cross-links and fibril architecture in fibrotic skin. J. Invest. Dermatol. 113, 617-621
44. Remst, D. F., Blaney Davidson, E. N., Vitters, E. L., Blom, A. B., Stoop, R., Snabel, J. M., Bank, R. A., van den Berg, W. B., and van der Kraan, P. M. (2013) Osteoarthritis-related fibrosis is associated with both elevated pyridinoline cross-link formation and lysyl hydroxylase 2b expression. Osteoarthritis Cartilage 21, 157-164
45. Bozóky, B., Savchenko, A., Csermely, P., Korcsmáros, T., Dúl, Z., Pontén, F., Székely, L., and Klein, G. (2013) Novel signatures of cancer-associated fibroblasts. Int. J. Cancer 133, 286-293
46. Rajkumar, T., Sabitha, K., Vijayalakshmi, N., Shirley, S., Bose, M. V., Gopal, G., and Selvaluxmy, G. (2011) Identification and validation of genes involved in cervical tumourigenesis. BMC Cancer 11, 80
47. Dong, S., Nutt, C. L., Betensky, R. A., Stemmer-Rachamimov, A. O., Denko, N. C., Ligon, K. L., Rowitch, D. H., and Louis, D. N. (2005) Histology-based expression profiling yields novel prognostic markers in human glioblastoma. J. Neuropathol. Exp. Neurol. 64, 948-955
48. Blanco, M. A., Le Roy, G., Khan, Z., Alečković, M., Zee, B. M., Garcia, B. A., and Kang, Y. (2012) Global secretome analysis identifies novel mediators of bone metastasis. Cell Res. 22, 1339-1355
49. Noda, T., Yamamoto, H., Takemasa, I., Yamada, D., Uemura, M., Wada, H., Kobayashi, S., Marubashi, S., Eguchi, H., Tanemura, M., Umeshita, K., Doki, Y., Mori, M., and Nagano, H. (2012) PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection. Liver Int. 32, 110-118
50. Ghosh, A. K., and Varga, J. (2007) The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. J. Cell. Physiol. 213, 663-671
51. Shi, Y., and Massagué, J. (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700
52. Zhang, W., Ou, J., Inagaki, Y., Greenwel, P., and Ramirez, F. (2000) Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor beta1 stimulation of α2(I)-collagen (COL1A2) transcription. J. Biol. Chem. 275, 39237-39245
53. Qin, H., Chan, M. W., Liyanarachchi, S., Balch, C., Potter, D., Souriraj, I. J., Cheng, A. S., Agosto-Perez, F. J., Nikonova, E. V., Yan, P. S., Lin, H. J., Nephew, K. P., Saltz, J. H., Showe, L. C., Huang, T. H., and Davuluri, R. V. (2009) An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules. BMC Syst. Biol. 3, 73
54. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S., and Gauthier, J. M. (1998) Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100
55. Seoane, J., Le, H. V., Shen, L., Anderson, S. A., and Massagué, J. (2004) Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117, 211-223
56. Qiu, P., Ritchie, R. P., Gong, X. Q., Hamamori, Y., and Li, L. (2006) Dynamic changes in chromatin acetylation and the expression of histone acetyltransferases and histone deacetylases regulate the SM22alpha transcription in response to Smad3-mediated TGFβ1 signaling. Biochem. Biophys. Res. Commun. 348, 351-358
57. Yuan, H., Reddy, M. A., Sun, G., Lanting, L., Wang, M., Kato, M., and Natarajan, R. (2013) Involvement of p300/CBP and epigenetic histone acetylation in TGF-1-mediated gene transcription in mesangial cells. Am. J. Physiol. Renal. Physiol. 304, F601-F613
58. Ihn, H., Yamane, K., Asano, Y., Jinnin, M., and Tamaki, K. (2006) Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts. Rheumatology 45, 157-165
59. Henry, R. A., Kuo, Y.-M. M., Bhattacharjee, V., Yen, T. J., and Andrews, A. J. (2015) Changing the selectivity of p300 by acetyl-CoA modulation of histone acetylation. ACS Chem. Biol. 10, 146-156
60. Voigt, P., Tee, W. W., and Reinberg, D. (2013) A double take on bivalent promoters. Genes Dev. 27, 1318-1338
61. Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., Jaenisch, R., Wagschal, A., Feil, R., Schreiber, S. L., and Lander, E. S. (2006) Abivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326
62. Sun, G., Reddy, M. A., Yuan, H., Lanting, L., Kato, M., and Natarajan, R. (2010) Epigenetic histone methylation modulates fibrotic gene expression. J. Am. Soc. Nephrol. 21, 2069-2080
63. Jørgensen, S., Schotta, G., and Sørensen, C. S. (2013) Histone H4 lysine 20 methylation: key player in epigenetic regulation of genomic integrity. Nucleic Acids Res. 41, 2797-2806
64. Evertts, A. G., Manning, A. L., Wang, X., Dyson, N. J., Garcia, B. A., and Coller, H. A. (2013) H4K20 methylation regulates quiescence and chromatin compaction. Mol. Biol. Cell 24, 3025-3037
65. Steger, D. J., Lefterova, M. I., Ying, L., Stonestrom, A. J., Schupp, M., Zhuo, D., Vakoc, A. L., Kim, J. E., Chen, J., Lazar, M. A., Blobel, G. A., and Vakoc, C. R. (2008) DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. Mol. Cell. Biol. 28, 2825-2839
66. Jacinto, F. V., Ballestar, E., and Esteller, M. (2009) Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation. Oncogene 28, 4212-4224